Target Name: IGHV3-37
NCBI ID: G28430
Review Report on IGHV3-37 Target / Biomarker Content of Review Report on IGHV3-37 Target / Biomarker
IGHV3-37
Other Name(s): 3-37P | IGHV337 | immunoglobulin heavy variable 3-37 (pseudogene) | Immunoglobulin heavy variable 3-37 (pseudogene)

IGHV3-37: A Protein Involved in Immunity and Inflammation

IGHV3-37 (3-37P) is a protein that is expressed in most tissues of the body. It is a member of the interleukin-gamma (IL-纬) family, which is a group of cytokines that play a crucial role in the immune response. The IL-纬 family includes many different subtypes, of which IGHV3-37 is one of them.

IGHV3-37 is a 19-kDa protein that is expressed in most tissues of the body. It is a member of the interleukin-gamma (IL-纬) family, which is a group of cytokines that play a crucial role in the immune response . IL-纬 family includes many different subtypes, such as 纬-未, 纬-蔚, 纬-渭, 纬-位, 纬-伪, and 纬-尾.

IGHV3-37 is a cytokine that is expressed in various tissues of the body, including the skin, muscle, heart, liver, and spleen. It is also expressed in the brain, where it has been shown to play a role in the development and progression of several neurological disorders, such as Alzheimer's disease and Parkinson's disease.

One of the unique features of IGHV3-37 is its ability to induce an immune response in humans. It is a potent ligand for the B cell receptor, which is a critical receptor for the immune system that allows for the development of antibodies as a means of fighting off infections. When IGHV3-37 is administered to mice, it is able to induce an immune response, including the production of antibodies and the activation of T cells.

IGHV3-37 has also been shown to play a role in the regulation of inflammation. In addition to its ability to induce an immune response, it is also known for its ability to regulate the activity of immune cells. This is done through its interaction with the nuclear factor kappa B (NF-kappa-B), a protein that is involved in the regulation of inflammation.

IGHV3-37 has also been shown to be involved in a number of signaling pathways that are important for cellular processes in the body. For example, it has been shown to play a role in the regulation of cell adhesion, as well as the regulation of cell growth and apoptosis.

In addition to its potential role in the immune system and inflammation, IGHV3-37 is also of interest as a potential drug target. Many studies have shown that IGHV3-37 is able to interact with a number of different proteins, including transcription factors, cytokines , and enzymes involved in cellular signaling pathways. This suggests that IGHV3-37 may be a useful target for the development of new drugs for a variety of diseases.

Overall, IGHV3-37 is a protein that is of interest as a potential drug target due to its ability to induce an immune response and its role in the regulation of inflammation. Further research is needed to fully understand the potential mechanisms of IGHV3-37 and its potential as a drug.

Protein Name: Immunoglobulin Heavy Variable 3-37 (pseudogene)

The "IGHV3-37 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHV3-37 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

IGHV3-38 | IGHV3-41 | IGHV3-42 | IGHV3-43 | IGHV3-47 | IGHV3-48 | IGHV3-49 | IGHV3-50 | IGHV3-52 | IGHV3-53 | IGHV3-54 | IGHV3-57 | IGHV3-6 | IGHV3-60 | IGHV3-62 | IGHV3-63 | IGHV3-64 | IGHV3-64D | IGHV3-65 | IGHV3-66 | IGHV3-69-1 | IGHV3-7 | IGHV3-71 | IGHV3-72 | IGHV3-73 | IGHV3-74 | IGHV3-75 | IGHV3-76 | IGHV3-79 | IGHV3-9 | IGHV3OR16-10 | IGHV3OR16-12 | IGHV3OR16-13 | IGHV3OR16-17 | IGHV3OR16-6 | IGHV3OR16-7 | IGHV3OR16-9 | IGHV4-28 | IGHV4-30-2 | IGHV4-31 | IGHV4-34 | IGHV4-39 | IGHV4-4 | IGHV4-55 | IGHV4-59 | IGHV4-61 | IGHV4-80 | IGHV5-10-1 | IGHV5-51 | IGHV5-78 | IGHV6-1 | IGHV7-27 | IGHV7-34-1 | IGHV7-4-1 | IGHV7-40 | IGHV7-56 | IGHV7-81 | IGHV8-51-1 | IGHVII-1-1 | IGHVII-15-1 | IGHVII-20-1 | IGHVII-22-1 | IGHVII-26-2 | IGHVII-28-1 | IGHVII-30-1 | IGHVII-31-1 | IGHVII-33-1 | IGHVII-40-1 | IGHVII-43-1 | IGHVII-44-2 | IGHVII-46-1 | IGHVII-49-1 | IGHVII-51-2 | IGHVII-60-1 | IGHVII-62-1 | IGHVII-65-1 | IGHVII-67-1 | IGHVII-74-1 | IGHVII-78-1 | IGHVIII-11-1 | IGHVIII-13-1 | IGHVIII-16-1 | IGHVIII-2-1 | IGHVIII-22-2 | IGHVIII-25-1 | IGHVIII-26-1 | IGHVIII-38-1 | IGHVIII-44 | IGHVIII-47-1 | IGHVIII-5-1 | IGHVIII-5-2 | IGHVIII-67-2 | IGHVIII-67-3 | IGHVIII-67-4 | IGHVIII-76-1 | IGHVIII-82 | IGHVIV-44-1 | IGIP | IGKC | IGKJ1